- Home
- CNA vs ASND Comparison
CNA vs ASND Comparison
Compare CNA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNA | ASND |
|---|---|---|
| Founded | 1853 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CNA | ASND |
|---|---|---|
| Price | $47.08 | $232.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 16 |
| Target Price | $53.00 | ★ $264.13 |
| AVG Volume (30 Days) | 333.2K | ★ 638.0K |
| Earning Date | 02-09-2026 | 02-11-2026 |
| Dividend Yield | ★ 8.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.66 | N/A |
| Revenue | ★ $14,850,000,000.00 | $758,592,045.00 |
| Revenue This Year | N/A | $99.54 |
| Revenue Next Year | $21.34 | $84.40 |
| P/E Ratio | $12.85 | ★ N/A |
| Revenue Growth | 5.41 | ★ 97.46 |
| 52 Week Low | $43.29 | $118.03 |
| 52 Week High | $51.34 | $238.84 |
Technical Indicators
Market Signals| Indicator | CNA | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 64.95 |
| Support Level | $45.72 | $200.69 |
| Resistance Level | $46.93 | $238.84 |
| Average True Range (ATR) | 0.75 | 12.24 |
| MACD | -0.02 | 2.39 |
| Stochastic Oscillator | 77.03 | 89.03 |
Price Performance
Historical ComparisonAbout CNA CNA Financial Corporation
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.